Search clinical trials for: Lenalidomide.
Total 1041 results
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
University Hospital, LilleCelgene CorporationCompletedWaldenstrom MacroglobulinemiaFrance
-
Mayo ClinicElgene ChemicalCompletedComplex Regional Pain Syndrome, Type 1United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMyelodysplastic SyndromeUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, IncCompleted
-
Celgene CorporationICON Clinical ResearchCompletedMyelodysplastic SyndromesGermany, Israel, United Kingdom, Spain, Belgium, Italy, France, Netherlands, Sweden
-
Boston VA Research Institute, Inc.Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical... and other collaboratorsCompletedMultiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
University Hospital, ToulouseCelgene Corporation; Janssen-Cilag Ltd.Completed
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
CelgeneCompletedMantle Cell LymphomaUnited States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Poitiers University HospitalCompletedMultiple Myeloma | Impaired Renal FunctionFrance
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnLymphoma | Follicular Lymphoma
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
Brown UniversityMemorial Hospital of Rhode Island; Roger Williams Medical CenterCompleted
-
CelgeneCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
European Organisation for Research and Treatment...TerminatedLymphomaAustria, Belgium, Spain, France, United Kingdom, Germany, Finland, Switzerland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
University of UlmTerminated
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory Peripheral T-cell LymphomaChina
-
CelgeneActive, not recruitingMultiple MyelomaNetherlands, Belgium, Denmark, Germany, United Kingdom, France, Norway, Spain, Austria, Ireland, Italy, Sweden
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
CelgeneTerminatedMultiple MyelomaChina
-
Nordic MDS GroupCompleted
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPeripheral T-cell Lymphomas (PTCL)Taiwan
-
Rush University Medical CenterCelgene CorporationTerminated
-
St. Joseph's Hospital and Medical Center, PhoenixTexas Tech UniversityNot yet recruitingCognitive Dysfunction | Neurodegenerative Disease, Hereditary | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
CelgeneCompletedLymphoma, Non-Hodgkin'sUnited States, Spain, Germany, France, Italy, Canada, United Kingdom
-
Center for International Blood and Marrow Transplant...Celgene Corporation; National Marrow Donor ProgramCompletedMultiple MyelomaUnited States
-
Technische Universität DresdenCelgene CorporationTerminatedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaGermany
-
Sutter Medical FoundationCompleted
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom